內(nèi)凝集蛋白1(ITLN1)多克隆抗體
Polyclonal Antibody to Intelectin 1 (ITLN1)
HL1; INTL; ITLN; LFR; HIntL; Omentin; Intelectin 1,Galactofuranose Binding; Intestinal Lactoferrin Receptor;Endothelial lectin HL-1
- 編號(hào)UPAA933Ra01
- 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPA933Ra01-內(nèi)凝集蛋白1(ITLN1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種Mus musculus (Mouse,小鼠)
- 應(yīng)用WB
 如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見流式抗體。
- 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 308 ¥ 718 ¥ 1026 ¥ 2565 ¥ 10260
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對(duì)ITLN1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ITLN1。
用法
            
                        免疫印跡:0.2-2μg/mL;1:250-2500
                        
 免疫組織化學(xué):5-20μg/mL;1:25-100
                        
 免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
                        
 最佳稀釋倍數(shù)最終由用戶決定。
                        
        
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
            抗體標(biāo)記定制服務(wù)
                    Protein-A/G純化柱
                    細(xì)胞和組織染色液
                    抗體陽性對(duì)照品
                    組織/切片定制服務(wù)
                    磷酸化抗體定制服務(wù)
                    免疫印跡(WB)實(shí)驗(yàn)服務(wù)
                    免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
                    免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
                    流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
                    免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
                    免疫熒光(IF)實(shí)驗(yàn)服務(wù)
                    緩沖液
                    DAB顯色試劑盒
                    SABC試劑盒
                    長臂生物素標(biāo)記試劑盒
                    實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
                            
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| URPA933Ra01 | 內(nèi)凝集蛋白1(ITLN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA933Ra01 | 內(nèi)凝集蛋白1(ITLN1)多克隆抗體 | WB | 
| ULAA933Ra71 | 內(nèi)凝集蛋白1(ITLN1)多克隆抗體(生物素標(biāo)記) | WB | 
| UMAA933Ra21 | 內(nèi)凝集蛋白1(ITLN1)單克隆抗體 | WB; IHC; ICC; IP. | 
| USEA933Ra | 內(nèi)凝集蛋白1(ITLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMA933Ra | 內(nèi)凝集蛋白1(ITLN1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Plos one | Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies [PubMed: PMC3612072] | 
| Rev Port Cardiol. | Serum visfatin and omentin levels in slow coronary flow [Pubmed:25481776] | 
| Thieme | Evaluation of the Relation Between Omentin-1 and Vitamin D in Postmenopausal Women With or Without Osteoporosis [DOI: 10.1055/s-0043-120110] | 
| Archives of Gynecology and Obstetrics | Maternal and neonatal omentin-1 levels in gestational diabetes [Pubmed:29335783] | 
| Journal of Cardiovascular Translational?Research | Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure [Pubmed: 30353296] | 
| Probiotics?and Antimicrobial?Proteins | Mitra Zarrati, Mahsa Raji Lahiji, Eisa Salehi, Bahareh Yazdani, Elham Razmpoosh, Raheleh Shokouhi Shoormasti & Farzad Shidfar [Pubmed: 30232744] | 
| Iranian Journal of Pediatrics | The Comparison of Cord Blood Omentin-1 Values of Newborns in the Different Birth Weights According to Gestational Age [] | 
| Mucosal Immunology | ASC and NLRP3 maintain innate immune homeostasis in the airway through an inflammasome-independent mechanism [Pubmed: 31278375] | 
| Nature Communications | ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment [Pubmed: 32669559] | 
| A New Biomarker Tool for Risk Stratification in ?°De Novo?± Acute Heart Failure (OROME) [] | |
| cells | The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure [Pubmed:35455943] | 

 
                     
                     
                            